Oral Candidal Carriage in Subjects with Pure Vegetarian and Mixed Dietary Habits
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 7
Abstract
Introduction: Candida albicans being a part of the normal oral microbial flora is one of the most commonly isolated species from the oral cavity. Recent studies have shown a steady rise in the number of non C. albicans species, which are relatively resistant to common antifungal agents and are being recognized as potential pathogens. It is vital to ascertain the predisposing factors leading to such a shift in the oral candidal flora. Aim: To estimate the prevalence of candidal species among vegetarians and non-vegetarians. Materials and Methods: Clinical data including age, gender, and diet preference of 238 participants were noted. Participants with a history of systemic disorders, oral prosthesis, salivary gland disorders and habits such as smoking, alcoholism, and tobacco usage were excluded from the study. The participants were asked to gargle a 10 ml solution of phosphate buffered saline for one minute before depositing the same in a sterile container. The samples were cultured using Hicrome agar media. Data analysis was carried out using Statistical Package for Social Sciences (SPSS software) version 10.5 and differences between individual groups were tested by Chi-square test. Results: Among 238 samples, 127 (53.3%) samples were positive for Candida. The candidal prevalence in vegetarians (68.5%) was higher than non-vegetarians (40.7%). C. albicans was the most common species to be isolated in both vegetarians (35.1%) and non-vegetarians (39.2%). Candida glabrata and Candida tropicalis showed a higher prevalence in vegetarians (30.5% and 10.1%, respectively) in comparison to non-vegetarians (8.4% and 2.3%, respectively). Candida krusei was isolated only from vegetarians (4.6%). Conclusion: Results indicate that diet plays a major role in oral candidal prevalence and species specificity which in turn may predispose the vegetarians toward these pathogenic organisms.
Authors and Affiliations
Shankargouda Patil, Roopa S Rao, A Thirumal Raj, D. S. Sanketh, Sachin Sarode, Gargi Sarode
Keywords
Related Articles
- EP ID EP356417
- DOI 10.7860/JCDR/2017/27717.10161
- Views 80
- Downloads 0
Cost Trend Analysis of Chronic Obstructive Pulmonary Disease among Vietnamese Patients: Findings from Two Provincial Facilities 2015–2017
ABSTRACT Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a serious public health concern and a leading cause of disability. Aim: To explore the direct medical costs associated with COPD and identify the key...
Renal Failure: The Most Important Prognostic Factor for Morbidity and Mortality in Patients Undergoing Open Elective Abdominal Aortic Aneurysm Repair
ABSTRACT Introduction: The elective abdominal aortic aneurysm repair leads to a remarkable decrease in the rupture of aneurysm and an increase in the life expectancy among patients. Aim: To study the mortality rate and c...
Pure Villous Adenoma of the Vesicoureteric Junction Presenting as Pyonephrosis
Villous adenomas of the urinary tract are uncommon neoplasms which share similar morphological features with gastrointestinal villous adenomas. Only two case series and around 20 scattered case reports of villous adenoma...
Rhino-Orbital-Cerebral Mucormycosis Causing Orbital Apex Syndrome and Blindness
ABSTRACT Mucormycosis is a potentially fatal fungal infection caused by a group of molds called mucormycetes. Rhino-Orbital-Cerebral Mucormycosis (ROCM) represents nearly half of all cases. This is the case of a 46-year-...
Evaluation of Efficacy and Safety of Epalrestat (150 mg) Compared to Epalrestat (50 mg) in Patients Suffering from Diabetic Peripheral Neuropathy
ABSTRACT Introduction: Epalrestat is currently the only Aldose Reductase Inhibitor (ARI) approved to treat symptoms of Diabetic Peripheral Neuropathy (DPN). The efficacy and safety of Epalrestat 50 mg TDS have been estab...